Brinker Capital’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-7,373
| Closed | -$2.02M | – | 978 |
|
2019
Q3 | $2.02M | Buy |
+7,373
| New | +$2.02M | 0.07% | 295 |
|
2019
Q2 | – | Sell |
-3,521
| Closed | -$1.77M | – | 956 |
|
2019
Q1 | $1.77M | Buy |
3,521
+845
| +32% | +$426K | 0.07% | 310 |
|
2018
Q4 | $1.32M | Sell |
2,676
-246
| -8% | -$121K | 0.06% | 327 |
|
2018
Q3 | $2.67M | Buy |
2,922
+707
| +32% | +$647K | 0.1% | 214 |
|
2018
Q2 | $1.62M | Buy |
2,215
+1,462
| +194% | +$1.07M | 0.06% | 339 |
|
2018
Q1 | $1.2M | Sell |
753
-617
| -45% | -$984K | 0.05% | 419 |
|
2017
Q4 | $1.23M | Sell |
1,370
-1,615
| -54% | -$1.45M | 0.05% | 367 |
|
2017
Q3 | $1.07M | Sell |
2,985
-11
| -0.4% | -$3.96K | 0.04% | 391 |
|
2017
Q2 | $879K | Buy |
2,996
+43
| +1% | +$12.6K | 0.04% | 396 |
|
2017
Q1 | $1.04M | Buy |
+2,953
| New | +$1.04M | 0.05% | 359 |
|